This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Translational Prostate Cancer
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
    • Trials in Progress
      • DORA - PCCTC
      • IRONMAN - PCCTC
      • PROMISE - PCCTC
      • SPLASH Trial
      • Oral EPI-7386
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2022
      • ASCO GU 2023
      • EAU 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology
  4. Renal Cancer
  5. Conferences

AUA 2014

Recent Abstracts
#AUA14 - Performance of multiparametric MRI for high grade prostate cancer: Correlation with whole-mount pathology - Session Highlights May 20, 2014
#AUA14 - Multiparametric MRI for detection of radio-recurrent prostate cancer: What constitutes an optimal dataset? - Session Highlights May 20, 2014
#AUA14 - External beam radiation therapy versus high-intensity focused ultrasound for localized prostate cancer: A matched pair comparison - Session Highlights May 20, 2014
#AUA14 - Magnetic resonance imaging/ultrasound fusion-guided biopsy for re-targeting of atypical small acinar proliferation - Session Highlights May 20, 2014
#AUA14 - Comparison of the Prostate Cancer Prevention Trial (PCPT) risk calculator and magnetic resonance imaging in selecting men for prostate biopsies - Session Highlights May 19, 2014
#AUA14 - Multiparametric magnetic resonance imaging and MRI/ultrasound fusion-guided biopsy stratify patients at risk for extracapsular extension at radical prostatectomy - Session Highlights May 19, 2014
#AUA14 - First surveillance image for patients with a small renal mass should not determine outcome: Results from the DISSRM registry - Session Highlights May 19, 2014
#AUA14 - Experience with active surveillance (AS) in patients with renal mass ≥ 4cm: Assessment of growth kinetics and outcomes - Session Highlights May 19, 2014
#AUA14 - Poorly functioning kidneys recover from ischemia during partial nephrectomy as well as strongly functioning kidneys - Session Highlights May 19, 2014
#AUA14 - Malignant renal tumors are associated with worsened baseline renal function than benign masses of equal size - Session Highlights May 19, 2014
#AUA14 - Tumor anatomic complexity predicts growth kinetics of renal masses under active surveillance - Session Highlights May 19, 2014
#AUA14 - Active surveillance for small renal masses non-inferior to primary intervention: 5-year analysis of the multi-institutional, prospective DISSRM (Delayed Intervention and Surveillance for Small Renal Masses) Registry - Session Highlights May 19, 2014
#AUA14 - Active surveillance, surgical management, and clinical outcomes of sporadic bilateral multifocal oncocytoma - Session Highlights May 19, 2014
#AUA14 - Poster: Performance of early radical cystectomy and risk of pathologic upstaging in patients with stage I high grade urothelial carcinoma of the bladder: A National Cancer Database analysis May 19, 2014
#AUA14 - Effects of diabetes on renal cancer prognosis - Session Highlights May 19, 2014
#AUA14 - Incidence of hybrid tumors found in excised renal masses: A multi-institutional analysis - Session Highlights May 19, 2014
#AUA14 - Critical Discussion: Mesh removal in the lower urinary tract - Slide Presentation May 19, 2014
#AUA14 - The role of obesity in the incidence of lymphatic spread, disease-free and overall survival: Data from the ARISER clinical trial - Session Highlights May 19, 2014
#AUA14 - Poster: Patients with anatomically “simple” renal masses are more likely to be placed on active surveillance than those with anatomically “complex” lesions May 19, 2014
#AUA14 - Survival and prognostic variables predicting survival in T4 renal cell carcinoma - Session Highlights May 19, 2014
Page 4 of 9
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free